USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Altea Therapeutics Corporation
City: Tucker
State: GA
Zip+4: 30084
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (678) 495-3108

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $403,662.00 5
SBIR Phase II $1,173,511.00 2

Award List:

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Harry K. Delcher
Award Amount: $99,442.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Harry K. Delcher
Award Amount: $97,910.00

NEEDLE FREE INSULIN INFUSION WITH THERMAL MICROPORATION

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Harry K. Delcher
Award Amount: $0.00
Abstract:
The goal of this proposal over Phase I and II SBIR studies and subsequent full scale development is to commercialize a noninvasive insulin infusion system that is painless, convenient, discrete, safe, efficacious and cost-effective. Such a system will bridge the gap between the tight glucose control… More

NEEDLE FREE INSULIN INFUSION WITH THERMAL MICROPORATION

Award Year / Program / Phase: 2002 / SBIR / Phase II
Agency: HHS
Principal Investigator: Harry K. Delcher
Award Amount: $391,878.00
Abstract:
The goal of this proposal over Phase I and II SBIR studies and subsequent full scale development is to commercialize a noninvasive insulin infusion system that is painless, convenient, discrete, safe, efficacious and cost-effective. Such a system will bridge the gap between the tight glucose control… More

RAPID TRANSDERMAL DELIVERY OF OPIOID PAIN MEDICATIONS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Alan M. Smith
Award Amount: $105,650.00
Abstract:
DESCRIPTION (provided by applicant): The American Medical Association reports that undertreatment of pain is a major problem for cancer patients as well as for other disease conditions. Approximately 50-75% of cancer patients have pain that is undertreated, and 25% die in severe unrelieved pain.… More

Transdermal Hydromorphone for Acute and Chronic Pain

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Alan M. Smith
Award Amount: $781,633.00
Abstract:
DESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently… More

Non-Invasive Drug Delivery by Thermal Microporation

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael Hatch
Award Amount: $100,660.00
Abstract:
DESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) transdermal drug delivery system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This… More